Skip to content

Abstract: Sustained Microbial Burden Reduction
and Impact on COVID19 Cases in a Long-Term Care Facility
through Advanced Photocatalysis (AP)

Abstract: Sustained Microbial Burden Reduction
and Impact on COVID19 Cases in a Long-Term Care Facility through Advanced Photocatalysis (AP)

The effect of the AP technology on environmental surface and floor aerobic bacteria, fungi, and Methicillin-resistant Staphylococcus aureus (MRSA) and airborne aerobic bacteria and fungi was designed as a prospective controlled experimental study, using pre-activation environmental samples as the baseline to compare to post-activation samples in the intervention center. Statistically significant reductions of greater than 92% were reported for all surface and floor samples after AP technology activation. Air testing showed reductions of aerobic bacteria and fungi by 87% and 36%, respectively, but were not statistically significant, likely due to small sample size (n=10). The intervention center performed 68% better than the control centers with a 79% reduction in staff COVID19 cases compared to the same matched time period one year prior. The incidence of resident COVID19 cases was reduced 94% in the intervention center while the control centers experienced a 46% increase compared to the matched time period one year prior.

Abstract Authors

Kim Trosch headshot squared v2

Kim Trosch

Director of Clinical Affairs, ActivePure Technologies

Trosch is a biomedical engineer and RN who is passionate about healthcare innovation that combines a variety of engineering techniques, clinical research, and extensive academic knowledge to solve real clinical problems. She is highly competent in carrying out clinical research and product integration while abiding by organizational rules and providing the highest level of patient satisfaction. Her studies included bachelor’s degrees in both Nursing and Biomedical Engineering and took place at Duquesne University where she was the first graduate with these dual degrees.

Amy Carenza headshot

Chief Commercial Officer, ActivePure Technologies

Carenza is responsible for the development and implementation of global strategy and sales for ActivePure Technology in corporate, institutional and healthcare end markets. Through this role, she helps organizations achieve their goals while keeping an eye on energy efficiency. Carenza has over 20 years of experience assisting mid-cap and large-cap companies identify and execute growth opportunities; her research and achievements in this vein have garnered multiple patents. Before joining ActivePure in 2021, Carenza enjoyed a distinguished career in financial services, most recently as a Managing Director at PNC.
Dr. Deborah Birx headshot v2

Deborah Birx, MD

Chief Medical & Science Advisor, ActivePure Technologies

Julie Britton headshot

Julie Britton, DNP, MSN, GCNS-BC, RN-BC, FGNLA

Chief Clinical Officer, Genesis Healthcare

Charmarie Adkins headshot

Charmarie Adkins, MSN, RN, CIC

Vice President of Infection Prevention, Genesis Healthcare

Learn More About the Technology: